价格图

    Palbocap

    • 电话报价

    分享

    描述

    Palbociclib is the first FDA-approved medication in a class of therapy called CDK 4/6 inhibitors. Taken in combination with certain hormonal therapies, Palbocap works to put the brakes on cell growth and division in hormone receptor positive, HER2- metastatic breast. INDICATION Palbocap is a prescription medicine used to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic) in combination with: An aromatase inhibitor as the first hormonal based therapy in women who have gone through menopause. Fulvestrant in women with disease progression following hormonal therapy.

    可显示的语言

    English
    پارسی
    中国
    Russian
    العربية
    Spanish
    Deutsch
    اردو
    Türkçe
    Français
    Italy
    Português
    Nederlands
    हिंदी
    Հայերեն
    请稍等片刻...